Clinical Trial Update: Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Aplidin in patients with primary myelofibrosis has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Aplidin (plitidepsin)

Snippet

Sponsor: PharmaMar | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12